Endometrial wavelike activity, endometrial thickness, and ultrasound texture in controlled ovarian hyperstimulation cycles.
OBJECTIVE
To describe endometrial wavelike activity, endometrial thickness, and texture in controlled ovarian hyperstimulation (COH) cycles.


METHODS
Prospective observational ultrasound study.


METHODS
University hospital-based infertility clinic.


METHODS
Thirty-five COH cycles in 19 women with unexplained infertility.


METHODS
Transvaginal ultrasound examination was performed throughout COH cycles. Intrauterine insemination was performed after hCG administration.


METHODS
Endometrial wavelike activity, wave frequency, wave velocity, endometrial thickness, and endometrial texture.


RESULTS
Endometrial wavelike activity increased from menstruation to ovulation and decreased in the luteal phase. On day hCG+2, endometrial wave-like activity was observed in all cycles. Waves from cervix to fundus prevailed in the periovulatory phase. Endometrial wavelike activity was related significantly to endometrial thickness at the start of ovarian stimulation and in the luteal phase. Endometrial thickness increased throughout the cycle. Endometrial texture showed periovulatory a triple-line aspect.


CONCLUSIONS
In COH cycles, endometrial wavelike activity is more pronounced than in spontaneous cycles. The number of follicles and endometrial wavelike activity were not correlated significantly. This is the first prospective study to provide longitudinal observational evidence that endometrial thickness increases throughout the COH cycle and that a triple line pattern develops.
Department of Obstetrics and Gynaecology, University Hospital Maastricht, The Netherlands.
M M
MM
Ijland
J L
JL
Evers
G A
GA
Dunselman
H J
HJ
Hoogland
D000328:Adult; D004717:Endometrium / Q000000981:diagnostic imaging / Q000187:drug effects*; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D008596:Menotropins / Q000627:therapeutic use*; D006080:Ovarian Follicle / Q000000981:diagnostic imaging / Q000187:drug effects; D016471:Ovarian Hyperstimulation Syndrome / Q000000981:diagnostic imaging*; D011446:Prospective Studies; D014463:Ultrasonography
D008596:Menotropins